KOREAMALL Trademark

Trademark Overview


On Friday, August 25, 2023, a trademark application was filed for KOREAMALL with the United States Patent and Trademark Office. The USPTO has given the KOREAMALL trademark a serial number of 98150217. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, October 30, 2024. This trademark is owned by Corporation Brandrefactoring. The KOREAMALL trademark is filed in the Pharmaceutical Products category with the following description:

Health food supplements; medicinal preparations for healthcare, namely, medicinal preparations for alleviating muscle pain, to improve antiinflammatory effect, to alleviate muscle fatigue and pain after exercise, to help improve arthritis symptoms, to improve allergies by reducing inflammation, to improve immunity, and to help fight against cancer; health food supplements primarily of methylsulfonylmethane; vitamin preparations in a form of food supplements; vitamin D preparations

General Information


Serial Number98150217
Word MarkKOREAMALL
Filing DateFriday, August 25, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording of "KOREAMALL" tilted upward with a curved tear drop shape above "KOREAMALL" and another curved tear drop shape below "KOREAMALL", the thicker portions on opposite sides, inside an inner circle that is inside an outer circle, with one five-pointed star on the left side and another five-pointed star on the right side in a space between the inner circle and the outer circle.
Goods and ServicesHealth food supplements; medicinal preparations for healthcare, namely, medicinal preparations for alleviating muscle pain, to improve antiinflammatory effect, to alleviate muscle fatigue and pain after exercise, to help improve arthritis symptoms, to improve allergies by reducing inflammation, to improve immunity, and to help fight against cancer; health food supplements primarily of methylsulfonylmethane; vitamin preparations in a form of food supplements; vitamin D preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorporation Brandrefactoring
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 06116
KR

Trademark Events


Event DateEvent Description
Tuesday, August 29, 2023NEW APPLICATION ENTERED
Monday, September 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 25, 2024NON-FINAL ACTION E-MAILED
Thursday, April 25, 2024NON-FINAL ACTION WRITTEN
Thursday, April 25, 2024ASSIGNED TO EXAMINER
Thursday, April 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 26, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 25, 2024NON-FINAL ACTION WRITTEN
Thursday, October 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2024NON-FINAL ACTION E-MAILED